Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

January 01, 1992; Volume 260,Issue 1
  • You have access
    Effect of chronic treatment with the calcium entry blocker, isradipine, on vascular calcium overload produced by vitamin D3 and nicotine in rats.
    D Henrion, J M Chillon, C Capdeville-Atkinson and J Atkinson
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 1-8;
  • You have access
    Comparison of mu opioid receptor binding on intact neuroblastoma cells with guinea pig brain and neuroblastoma cell membranes.
    L Toll
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 9-15;
  • You have access
    Regulation of 5-hydroxytryptamine1A receptor function in rat hippocampus by short- and long-term administration of 5-hydroxytryptamine1A agonist and antidepressants.
    M E Newman, B Shapira and B Lerer
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 16-20;
  • You have access
    Design of an irreversible affinity ligand for the phencyclidine recognition site on N-methyl-D-aspartate-type glutamate receptors.
    S O Casalotti, A P Kozikowski, A Fauq, W Tückmantel and K E Krueger
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 21-28;
  • You have access
    The acute renal actions of angiotensin converting enzyme inhibitors in the sodium-depleted conscious primate are mediated by inhibition of the renin-angiotensin system.
    U Humke, N Levens, J Wood and K Hofbauer
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 29-35;
  • You have access
    In vivo characterization of the pharmacodynamic interaction of a benzodiazepine agonist and antagonist: midazolam and flumazenil.
    J W Mandema, E Tukker and M Danhof
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 36-44;
  • You have access
    The sympathetic nervous system facilitates endothelin-1 effects on venous tone.
    R P Waite and C C Pang
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 45-50;
  • You have access
    Preclinical studies on LY237733, a potent and selective serotonergic antagonist.
    M M Foreman, R W Fuller, D L Nelson, D O Calligaro, K D Kurz, J W Misner, W L Garbrecht and C J Parli
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 51-57;
  • You have access
    Electrophysiological actions of the pimobendan metabolite, UD-CG 212 Cl, in guinea pig myocardium.
    M V Westfall, G M Wahler, K Fujino and R J Solaro
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 58-63;
  • You have access
    Comparison of the thrombolytic activity of the novel plasminogen activator, LY210825, to anisoylated plasminogen-streptokinase activator complex in a canine model of coronary artery thrombolysis.
    C V Jackson, J D Frank, T J Craft, J L Sundboom and G F Smith
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 64-70;
  • You have access
    Differences in teniposide disposition and pharmacodynamics in patients with newly diagnosed and relapsed acute lymphocytic leukemia.
    W E Evans, J H Rodman, M V Relling, W P Petros, C F Stewart, C H Pui and G K Rivera
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 71-77;
  • You have access
    Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats.
    J H Kehne, T C McCloskey, V L Taylor, C K Black, G M Fadayel and C J Schmidt
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 78-89;
  • You have access
    Receptor-coupled G proteins mediate contraction and Ca++ mobilization in isolated intestinal muscle cells.
    K S Murthy, J R Grider and G M Makhlouf
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 90-97;
  • You have access
    Omega-conotoxin-sensitive calcium channels modulate autonomic neurotransmission in guinea pig airways.
    R J Altiere, L Diamond and D C Thompson
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 98-103;
  • You have access
    Cyclooxygenase dependency of the renovascular actions of cytochrome P450-derived arachidonate metabolites.
    M A Carroll, M P Garcia, J R Falck and J C McGiff
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 104-109;
  • You have access
    Block of sodium channel current by anticonvulsant U-54494A in mouse neuroblastoma cells.
    Y Zhu and W B Im
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 110-116;
  • You have access
    A proposed mechanism of action for the antinociceptive effect of intrathecally administered calcium in the mouse.
    S P Welch, D L Stevens and W L Dewey
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 117-127;
  • You have access
    Effect of 3'-azido-3'-deoxythymidine (AZT) on organic ion transport in rat renal brush border membrane vesicles.
    D A Griffiths, S D Hall and P P Sokol
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 128-133;
  • You have access
    Characterization of receptors involved in dopamine-induced activation of phospholipase-C in rat renal cortex.
    S J Vyas, J Eichberg and M F Lokhandwala
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 134-139;
  • You have access
    Antagonists of nitric oxide synthesis inhibit nerve-mediated relaxations of longitudinal muscle in guinea pig ileum.
    L E Osthaus and J J Galligan
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 140-145;
  • You have access
    Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598).
    A A Megens, F H Awouters, T F Meert, K H Schellekens, C J Niemegeers and P A Janssen
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 146-159;
  • You have access
    Behavioral disinhibition and depression in amphetaminized rats: a comparison of risperidone, ocaperidone and haloperidol.
    A A Megens, C J Niemegeers and F H Awouters
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 160-167;
  • You have access
    Paradoxical effect of chronic fentanyl treatment on naltrexone-induced supersensitivity and upregulation.
    F J Ayesta, A Ableitner, M W Emmett-Oglesby, A Herz and T S Shippenberg
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 168-174;
  • You have access
    Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, SK&F 108566.
    R M Edwards, N Aiyar, E H Ohlstein, E F Weidley, E Griffin, M Ezekiel, R M Keenan, R R Ruffolo and J Weinstock
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 175-181;
  • You have access
    After GM1 ganglioside treatment of sensory neurons naloxone paradoxically prolongs the action potential but still antagonizes opioid inhibition.
    S M Crain and K F Shen
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 182-186;
  • You have access
    Multiple actions of the leukotriene B4 receptor antagonist SC-41930.
    D Villani-Price, D C Yang, R E Walsh, D J Fretland, R H Keith, G Kocan, J F Kachur, T S Gaginella and B S Tsai
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 187-191;
  • You have access
    Evidence for a noradrenergic innervation to "atypical" beta adrenoceptors (or putative beta-3 adrenoceptors) in the ileum of guinea pig.
    D T Taneja and D E Clarke
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 192-200;
  • You have access
    Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents.
    D R Compton, M R Johnson, L S Melvin and B R Martin
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 201-209;
  • You have access
    Chronic marijuana smoke exposure in the rhesus monkey. II: Effects on progressive ratio and conditioned position responding.
    M G Paule, R R Allen, J R Bailey, A C Scallet, S F Ali, R M Brown and W Slikker
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 210-222;
  • You have access
    In vivo evaluation of the antagonist activity of angiotensin I analogs.
    E K Jackson
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 223-231;
  • You have access
    N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. I. Location on axon terminals and pharmacological characterization.
    A Pittaluga and M Raiteri
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 232-237;
  • You have access
    N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. II. Evidence for functional cooperation and for coexistence on the same axon terminal.
    M Raiteri, B Garrone and A Pittaluga
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 238-242;
  • You have access
    Effect of long-acting calcium entry blocker (anipamil) on blood pressure, renal function and survival of uremic rats.
    C Jarusiripipat, L Chan, J I Shapiro and R W Schrier
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 243-247;
  • You have access
    Different mechanisms of relaxation of pig coronary artery to bradykinin and cromakalim are distinguished by potassium channel blockers.
    C L Cowan and R A Cohen
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 248-253;
  • You have access
    Effects of diazoxide and glyburide on ATP-sensitive K+ channels from hypertrophied ventricular myocytes.
    F Ciampolillo, D E Tung and J S Cameron
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 254-260;
  • You have access
    Cromakalim effects of acetylcholine-induced changes in cytosolic calcium and tension in swine trachealis.
    C C Shieh, M F Petrini, T M Dwyer and J M Farley
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 261-268;
  • You have access
    Effect of fenoldopam on the acute and subacute nephrotoxicity produced by amphotericin B in the dog.
    A J Nichols, P F Koster, D P Brooks and R R Ruffolo
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 269-274;
  • You have access
    Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic.
    R B Raffa, E Friderichs, W Reimann, R P Shank, E E Codd and J L Vaught
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 275-285;
  • You have access
    Lack of tolerance to a 24-hour infusion of S-nitroso N-acetylpenicillamine (SNAP) in conscious rabbits.
    J E Shaffer, B J Han, W H Chern and F W Lee
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 286-293;
  • You have access
    Effects of captopril on blood pressure, placental blood flow and uterine oxygen consumption in pregnant rabbits.
    N D Binder and J J Faber
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 294-299;
  • You have access
    Anti-inflammatory activity of BF389, a Di-T-butylphenol, in animal models of arthritis.
    A M Bendele, D N Benslay, J T Hom, S M Spaethe, K J Ruterbories, T D Lindstrom, S J Lee and R W Naismith
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 300-305;
  • You have access
    Differential inhibition of cholinergic and noncholinergic neurogenic contractions by 5-hydroxytryptamine1A receptor agonists in guinea pig ileum.
    J J Galligan
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 306-312;
  • You have access
    Misoprostol accelerates colonic mucosal repair in acetic acid-induced colitis.
    T Yamada, K Fujimoto, P Tso, T Fujimoto, T S Gaginella and M B Grisham
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 313-318;
  • You have access
    The biochemistry and pharmacology of PD 116124 (8-amino-2'-nordeoxyguanosine), an inhibitor of purine nucleoside phosphorylase (PNP).
    M K Dong, M E Scott, D J Schrier, M J Suto, J C Sircar, A Black, T Chang and R B Gilbertsen
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 319-326;
  • You have access
    Agonist and antagonist activity of kappa opioids in the squirrel monkey: I. Antinociception and urine output.
    R M Craft and L A Dykstra
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 327-333;
  • You have access
    Agonist and antagonist activity of kappa opioids in the squirrel monkey: II. Effect of chronic morphine treatment.
    R M Craft and L A Dykstra
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 334-342;
  • You have access
    Cholecystokinin release from the rat caudate-putamen, cortex and hippocampus is increased by activation of the D1 dopamine receptor.
    J S Brog and M C Beinfeld
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 343-348;
  • You have access
    Captopril and ANP: changes in renal hemodynamics, glomerular-ANP receptors and guanylate cyclase activity in rats with heart failure.
    R W Lee, T E Raya, U Michael, S Foster, T Meeks and S Goldman
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 349-354;
  • You have access
    Clinical characteristics of naloxone-precipitated withdrawal in human opioid-dependent subjects.
    P D Kanof, L Handelsman, M J Aronson, R Ness, K J Cochrane and K J Rubinstein
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 355-363;
  • You have access
    Opposite effects of enantiomers of clofibric acid derivative on rat skeletal muscle chloride conductance: antagonism studies and theoretical modeling of two different receptor site interactions.
    A De Luca, D Tricarico, R Wagner, S H Bryant, V Tortorella and D Conte Camerino
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 364-368;
  • You have access
    Effects of the amphiphilic peptides melittin and mastoparan on calcium influx, phosphoinositide breakdown and arachidonic acid release in rat pheochromocytoma PC12 cells.
    O H Choi, W L Padgett and J W Daly
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 369-375;
  • You have access
    Use-, concentration- and voltage-dependent limitation by MK-801 of action potential firing frequency in mouse central neurons in cell culture.
    A W Wamil and M J McLean
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 376-383;
  • You have access
    Characterization of kinin receptors on human synovial cells and upregulation of receptor number by interleukin-1.
    J M Bathon, D C Manning, D W Goldman, M C Towns and D Proud
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 384-392;
  • You have access
    Methimazole protection of rats against chemically induced kidney damage in vivo.
    P J Sausen, A A Elfarra and A J Cooley
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 393-401;
  • You have access
    Opposite effects of NMDA receptor blockade on dopaminergic D1- and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression.
    M Morelli, S Fenu, A Pinna and G Di Chiara
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 402-408;
  • You have access
    D1 receptor stimulation inhibits dopamine cell activity after reserpine treatment but not after chronic SCH 23390: an effect blocked by N-methyl-D-aspartate antagonists.
    K X Huang and J R Walters
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 409-416;
  • You have access
    The insulin-secreting cell line, RINm5F, expresses an alpha-2D adrenoceptor and nonadrenergic idazoxan-binding sites.
    A Remaury and H Paris
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 417-426;
  • You have access
    [3H]nisoxetine: a radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding.
    S M Tejani-Butt
    Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 427-436;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 260, Issue 1
1 Jan 1992
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics